{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:05:14Z","timestamp":1791993914385,"version":"4.4.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2010,5,27]],"date-time":"2010-05-27T00:00:00Z","timestamp":1274918400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Hum Genet"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1038\/jhg.2010.58","type":"journal-article","created":{"date-parts":[[2010,5,27]],"date-time":"2010-05-27T06:10:58Z","timestamp":1274940658000},"page":"512-517","source":"Crossref","is-referenced-by-count":51,"title":["Mutations of the GLA gene in Korean patients with Fabry disease and frequency of the E66Q allele as a functional variant in Korean newborns"],"prefix":"10.1038","volume":"55","author":[{"given":"Beom Hee","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Hee","family":"Heo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gu-Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo-Shik","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duk-Hee","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Hoon","family":"Choe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won-Ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song Hyun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Wook","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,5,27]]},"reference":[{"key":"BFjhg201058_CR1","doi-asserted-by":"publisher","first-page":"3301","DOI":"10.1093\/nar\/17.8.3301","volume":"17","author":"R Kornreich","year":"1989","unstructured":"Kornreich, R., Desnick, R. J. & Bishop, D. F. Nucleotide sequence of the human alpha-galactosidase A gene. Nucleic Acids Res. 17, 3301\u20133302 (1989).","journal-title":"Nucleic Acids Res."},{"key":"BFjhg201058_CR2","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1001\/jama.281.3.249","volume":"281","author":"PJ Meikle","year":"1999","unstructured":"Meikle, P. J., Hopwood, J. J., Clague, A. E. & Carey, W. F. Prevalence of lysosomal storage disorders. JAMA 281, 249\u2013254 (1999).","journal-title":"JAMA"},{"key":"BFjhg201058_CR3","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/S0140-6736(08)61589-5","volume":"372","author":"YA Zarate","year":"2008","unstructured":"Zarate, Y. A. & Hopkin, R. J. Fabry's disease. Lancet 372, 1427\u20131435 (2008).","journal-title":"Lancet"},{"key":"BFjhg201058_CR4","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1002\/humu.21074","volume":"30","author":"WL Hwu","year":"2009","unstructured":"Hwu, W. L., Chien, Y. H., Lee, N. C., Chiang, S. C., Dobrovolny, R., Huang, A. C. et al. Newborn screening for Fabry disease in Taiwan reveals a high incidence of the later-onset GLA mutation c.936+919G>A (IVS4+919G>A). Hum. Mutat. 30, 1397\u20131405 (2009).","journal-title":"Hum. Mutat."},{"key":"BFjhg201058_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1086\/504601","volume":"79","author":"M Spada","year":"2006","unstructured":"Spada, M., Pagliardini, S., Yasuda, M., Tukel, T., Thiagarajan, G., Sakuraba, H. et al. High incidence of later-onset fabry disease revealed by newborn screening. Am. J. Hum. Genet. 79, 31\u201340 (2006).","journal-title":"Am. J. Hum. Genet."},{"key":"BFjhg201058_CR6","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1097\/01.gim.0000237866.70357.c6","volume":"8","author":"CM Eng","year":"2006","unstructured":"Eng, C. M., Germain, D. P., Banikazemi, M., Warnock, D. G., Wanner, C., Hopkin, R. J. et al. Fabry disease: guidelines for the evaluation and management of multi-organ system involvement. Genet. Med. 8, 539\u2013548 (2006).","journal-title":"Genet. Med."},{"key":"BFjhg201058_CR7","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1006\/bbrc.1993.2659","volume":"197","author":"S Ishii","year":"1993","unstructured":"Ishii, S., Kase, R., Sakuraba, H. & Suzuki, Y. Characterization of a mutant alpha-galactosidase gene product for the late-onset cardiac form of Fabry disease. Biochem. Biophys. Res. Commun. 197, 1585\u20131589 (1993).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFjhg201058_CR8","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1056\/NEJM199508033330504","volume":"333","author":"S Nakao","year":"1995","unstructured":"Nakao, S., Takenaka, T., Maeda, M., Kodama, C., Tanaka, A., Tahara, M. et al. An atypical variant of Fabry's disease in men with left ventricular hypertrophy. N Engl. J. Med. 333, 288\u2013293 (1995).","journal-title":"N Engl. J. Med."},{"key":"BFjhg201058_CR9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0002-9149(00)01275-3","volume":"87","author":"T Yoshitama","year":"2001","unstructured":"Yoshitama, T., Nakao, S., Takenaka, T., Teraguchi, H., Sasaki, T., Kodama, C. et al. Molecular genetic, biochemical, and clinical studies in three families with cardiac Fabry's disease. Am. J. Cardiol. 87, 71\u201375 (2001).","journal-title":"Am. J. Cardiol."},{"key":"BFjhg201058_CR10","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1016\/j.jacc.2007.06.062","volume":"50","author":"L Monserrat","year":"2007","unstructured":"Monserrat, L., Gimeno-Blanes, J. R., Marin, F., Hermida-Prieto, M., Garcia-Honrubia, A., Perez, I. et al. Prevalence of fabry disease in a cohort of 508 unrelated patients with hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 50, 2399\u20132403 (2007).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFjhg201058_CR11","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1046\/j.1523-1755.2003.00160.x","volume":"64","author":"S Nakao","year":"2003","unstructured":"Nakao, S., Kodama, C., Takenaka, T., Tanaka, A., Yasumoto, Y., Yoshida, A. et al. Fabry disease: detection of undiagnosed hemodialysis patients and identification of a \u2018renal variant\u2019 phenotype. Kidney Int. 64, 801\u2013807 (2003).","journal-title":"Kidney Int."},{"key":"BFjhg201058_CR12","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1097\/01.ASN.0000124671.61963.1E","volume":"15","author":"P Kotanko","year":"2004","unstructured":"Kotanko, P., Kramar, R., Devrnja, D., Paschke, E., Voigtlander, T., Auinger, M. et al. Results of a nationwide screening for Anderson-Fabry disease among dialysis patients. J. Am. Soc. Nephrol. 15, 1323\u20131329 (2004).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFjhg201058_CR13","doi-asserted-by":"publisher","first-page":"281","DOI":"10.5414\/CNP64281","volume":"64","author":"M Tanaka","year":"2005","unstructured":"Tanaka, M., Ohashi, T., Kobayashi, M., Eto, Y., Miyamura, N., Nishida, K. et al. Identification of Fabry's disease by the screening of alpha-galactosidase A activity in male and female hemodialysis patients. Clin. Nephrol. 64, 281\u2013287 (2005).","journal-title":"Clin. Nephrol."},{"key":"BFjhg201058_CR14","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s10157-005-0369-4","volume":"9","author":"M Ichinose","year":"2005","unstructured":"Ichinose, M., Nakayama, M., Ohashi, T., Utsunomiya, Y., Kobayashi, M. & Eto, Y. Significance of screening for Fabry disease among male dialysis patients. Clin. Exp. Nephrol. 9, 228\u2013232 (2005).","journal-title":"Clin. Exp. Nephrol."},{"key":"BFjhg201058_CR15","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1016\/S0140-6736(05)67635-0","volume":"366","author":"A Rolfs","year":"2005","unstructured":"Rolfs, A., Bottcher, T., Zschiesche, M., Morris, P., Winchester, B., Bauer, P. et al. Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study. Lancet 366, 1794\u20131796 (2005).","journal-title":"Lancet"},{"key":"BFjhg201058_CR16","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1006\/abbi.2000.1743","volume":"377","author":"S Ishii","year":"2000","unstructured":"Ishii, S., Suzuki, Y. & Fan, J. Q. Role of Ser-65 in the activity of alpha-galactosidase A: characterization of a point mutation (S65T) detected in a patient with Fabry disease. Arch. Biochem. Biophys. 377, 228\u2013233 (2000).","journal-title":"Arch. Biochem. Biophys."},{"key":"BFjhg201058_CR17","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1042\/BJ20070479","volume":"406","author":"S Ishii","year":"2007","unstructured":"Ishii, S., Chang, H. H., Kawasaki, K., Yasuda, K., Wu, H. L., Garman, S. C. et al. Mutant alpha-galactosidase A enzymes identified in Fabry disease patients with residual enzyme activity: biochemical characterization and restoration of normal intracellular processing by 1-deoxygalactonojirimycin. Biochem J. 406, 285\u2013295 (2007).","journal-title":"Biochem J."},{"key":"BFjhg201058_CR18","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0925-4439(00)00024-7","volume":"1501","author":"R Kase","year":"2000","unstructured":"Kase, R., Bierfreund, U., Klein, A., Kolter, T., Utsumi, K., Itoha, K. et al. Characterization of two alpha-galactosidase mutants (Q279E and R301Q) found in an atypical variant of Fabry disease. Biochim. Biophys. Acta. 1501, 227\u2013235 (2000).","journal-title":"Biochim. Biophys. Acta."},{"key":"BFjhg201058_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3858\/emm.2009.41.1.001","volume":"41","author":"JY Park","year":"2009","unstructured":"Park, J. Y., Kim, G. H., Kim, S. S., Ko, J. M., Lee, J. J. & Yoo, H. W. Effects of a chemical chaperone on genetic mutations in alpha-galactosidase A in Korean patients with Fabry disease. Exp. Mol. Med. 41, 1\u20137 (2009).","journal-title":"Exp. Mol. Med."},{"key":"BFjhg201058_CR20","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1006\/bbrc.1995.2416","volume":"214","author":"T Okumiya","year":"1995","unstructured":"Okumiya, T., Ishii, S., Takenaka, T., Kase, R., Kamei, S., Sakuraba, H. et al. Galactose stabilizes various missense mutants of alpha-galactosidase in Fabry disease. Biochem. Biophys. Res. Commun. 214, 1219\u20131224 (1995).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFjhg201058_CR21","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3346\/jkms.2008.23.2.243","volume":"23","author":"JH Choi","year":"2008","unstructured":"Choi, J. H., Cho, Y. M., Suh, K. S., Yoon, H. R., Kim, G. H., Kim, S. S. et al. Short-term efficacy of enzyme replacement therapy in Korean patients with Fabry disease. J. Korean Med. Sci. 23, 243\u2013250 (2008).","journal-title":"J. Korean Med. Sci."},{"key":"BFjhg201058_CR22","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1034\/j.1399-0004.2000.580311.x","volume":"58","author":"JK Lee","year":"2000","unstructured":"Lee, J. K., Kim, G. H., Kim, J. S., Kim, K. K., Lee, M. C. & Yoo, H. W. Identification of four novel mutations in five unrelated Korean families with Fabry disease. Clin. Genet. 58, 228\u2013233 (2000).","journal-title":"Clin. Genet."},{"key":"BFjhg201058_CR23","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1021\/ac00047a015","volume":"64","author":"KA Kayganich","year":"1992","unstructured":"Kayganich, K. A. & Murphy, R. C. Fast atom bombardment tandem mass spectrometric identification of diacyl, alkylacyl, and alk-1-enylacyl molecular species of glycerophosphoethanolamine in human polymorphonuclear leukocytes. Anal. Chem. 64, 2965\u20132971 (1992).","journal-title":"Anal. Chem."},{"key":"BFjhg201058_CR24","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1139\/y59-099","volume":"37","author":"EG Bligh","year":"1959","unstructured":"Bligh, E. G. & Dyer, W. J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37, 911\u2013917 (1959).","journal-title":"Can. J. Biochem. Physiol."},{"key":"BFjhg201058_CR25","first-page":"157","volume":"81","author":"RJ Desnick","year":"1973","unstructured":"Desnick, R. J., Allen, K. Y., Desnick, S. J., Raman, M. K., Bernlohr, R. W. & Krivit, W. Fabry's disease: enzymatic diagnosis of hemizygotes and heterozygotes. Alpha-galactosidase activities in plasma, serum, urine, and leukocytes. J. Lab. Clin. Med. 81, 157\u2013171 (1973).","journal-title":"J. Lab. Clin. Med."},{"key":"BFjhg201058_CR26","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1002\/humu.9327","volume":"25","author":"E Schafer","year":"2005","unstructured":"Schafer, E., Baron, K., Widmer, U., Deegan, P., Neumann, H. P., Sunder-Plassmann, G. et al. Thirty-four novel mutations of the GLA gene in 121 patients with Fabry disease. Hum. Mutat. 25, 412 (2005).","journal-title":"Hum. Mutat."},{"key":"BFjhg201058_CR27","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1161\/01.CIR.0000012626.81324.38","volume":"105","author":"B Sachdev","year":"2002","unstructured":"Sachdev, B., Takenaka, T., Teraguchi, H., Tei, C., Lee, P., McKenna, W. J. et al. Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy. Circulation 105, 1407\u20131411 (2002).","journal-title":"Circulation"},{"key":"BFjhg201058_CR28","doi-asserted-by":"publisher","first-page":"601","DOI":"10.2169\/internalmedicine.39.601","volume":"39","author":"S Okuda","year":"2000","unstructured":"Okuda, S. Renal involvement in Fabry's disease. Intern. Med. 39, 601\u2013602 (2000).","journal-title":"Intern. Med."},{"key":"BFjhg201058_CR29","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1542\/peds.2004-1678","volume":"115","author":"M Ries","year":"2005","unstructured":"Ries, M., Gupta, S., Moore, D. F., Sachdev, V., Quirk, J. M., Murray, G. J. et al. Pediatric Fabry disease. Pediatrics 115, e344\u2013e355 (2005).","journal-title":"Pediatrics"},{"key":"BFjhg201058_CR30","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s00431-003-1299-3","volume":"162","author":"M Ries","year":"2003","unstructured":"Ries, M., Ramaswami, U., Parini, R., Lindblad, B., Whybra, C., Willers, I. et al. The early clinical phenotype of Fabry disease: a study on 35 European children and adolescents. Eur. J. Pediatr. 162, 767\u2013772 (2003).","journal-title":"Eur. J. Pediatr."},{"key":"BFjhg201058_CR31","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1651-2227.2007.00198.x","volume":"96","author":"SC Garman","year":"2007","unstructured":"Garman, S. C. Structure-function relationships in alpha-galactosidase A. Acta. Paediatr. Suppl. 96, 6\u201316 (2007).","journal-title":"Acta. Paediatr. Suppl."},{"key":"BFjhg201058_CR32","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.jmb.2004.01.035","volume":"337","author":"SC Garman","year":"2004","unstructured":"Garman, S. C. & Garboczi, D. N. The molecular defect leading to Fabry disease: structure of human alpha-galactosidase. J. Mol. Biol. 337, 319\u2013335 (2004).","journal-title":"J. Mol. Biol."},{"key":"BFjhg201058_CR33","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/humu.10275","volume":"22","author":"M Yasuda","year":"2003","unstructured":"Yasuda, M., Shabbeer, J., Benson, S. D., Maire, I., Burnett, R. M. & Desnick, R. J. Fabry disease: characterization of alpha-galactosidase A double mutations and the D313Y plasma enzyme pseudodeficiency allele. Hum. Mutat. 22, 486\u2013492 (2003).","journal-title":"Hum. Mutat."},{"key":"BFjhg201058_CR34","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S0005-2760(96)00175-0","volume":"1345","author":"J Ledvinova","year":"1997","unstructured":"Ledvinova, J., Poupetova, H., Hanackova, A., Pisacka, M. & Elleder, M. Blood group B glycosphingolipids in alpha-galactosidase deficiency (Fabry disease): influence of secretor status. Biochim. Biophys. Acta. 1345, 180\u2013187 (1997).","journal-title":"Biochim. Biophys. Acta."}],"container-title":["Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/jhg201058.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/jhg201058","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/jhg201058.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:27:36Z","timestamp":1684430856000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/jhg201058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,27]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["BFjhg201058"],"URL":"https:\/\/doi.org\/10.1038\/jhg.2010.58","relation":{},"ISSN":["1434-5161","1435-232X"],"issn-type":[{"value":"1434-5161","type":"print"},{"value":"1435-232X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,27]]}}}